Noninvasive urinary miRNA biomarkers for early detection of pancreatic adenocarcinoma

Currently, the majority of patients diagnosed with pancreatic ductal adenocarcinoma (PDAC) present with locally invasive and/or metastatic disease, resulting in five-year survival of less than 5%. The development of an early diagnostic test is, therefore, expected to significantly impact the patient...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Am J Cancer Res
Main Authors: Debernardi, Silvana, Massat, Nathalie J, Radon, Tomasz P, Sangaralingam, Ajanthah, Banissi, Ana, Ennis, Darren P, Dowe, Thomas, Chelala, Claude, Pereira, Stephen P, Kocher, Hemant M, Young, Bryan D, Bond-Smith, Giles, Hutchins, Robert, Crnogorac-Jurcevic, Tatjana
Format: Artigo
Jezik:Inglês
Izdano: e-Century Publishing Corporation 2015
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4697691/
https://ncbi.nlm.nih.gov/pubmed/26807325
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki